Unser Haushund: Eine Spitzmaus im Wolfspelz? - Wolf-Ekkehard ...

Unser Haushund: Eine Spitzmaus im Wolfspelz? - Wolf-Ekkehard ... Unser Haushund: Eine Spitzmaus im Wolfspelz? - Wolf-Ekkehard ...

13.07.2015 Aufrufe

230ersten Hinweise auf eventuelle Folgen von Fehlfunktionen entnehmen; weitereInformationen in den aufgeführten Quellen):FGF4, fibroblast growth factor 4 (codiert für 206 amino acids)"Subunit: Interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) andtheir receptors is increased by heparan sulfate glycosaminoglycans that function as coreceptors.”"Fibroblast growth factor 4 is a protein that in humans is encoded by the FGF4 gene.[1][2]The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family memberspossess broad mitogenic and cell survival activities and are involved in a variety of biological processes includingembryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene wasidentified by its oncogenic transforming activity. This gene and FGF3, another oncogenic growth factor, are locatedclosely on chromosome 11. Co-amplification of both genes was found in various kinds of human tumors. Studies on themouse homolog suggested a function in bone morphogenesis and limb development through the sonic hedgehog (SHH)signaling pathway.[2]" 418FGF5, fibroblast growth factor 5 (codiert für 268 amino acids)"Subunit: Interacts with FGFR1 and FGFR2.” 419"The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family memberspossess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, includingembryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene wasidentified as an oncogene, which confers transforming potential when transfected into mammalian cells. Targeteddisruption of the homolog of this gene in mouse resulted in the phenotype of abnormally long hair, which suggested afunction as an inhibitor of hair elongation. Alternatively spliced transcript variants encoding different isoforms havebeen identified.[3]The disruption of FGF5 expression in mammals increases the length of the anagen (growth) phase of the haircycle, resulting in a phenotype of extremely long hair. This has been shown in many species, including cats,[4]dogs,[5] mice,[6] rabbits, sheep and goats (the so-called angora mutation)[7][8] and even elephants andmammoths.[9] FGF5 also affects the hair cycle in humans; blocking FGF5 in the human scalp (by applying a herbalextract that blocked FGF5) extends the hair cycle, resulting in less hair fall and increased hair growth.[10]." 420FGF19, fibroblast growth factor 19 (codiert für 216 amino acids)"Function: Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression,following positive regulation of the JNK and ERK1/2 cascades. Stimulates glucose uptake in adipocytes. Activityrequires the presence of KLB and FGFR4."http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF19&search=FGF19"This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected onlyin fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to berequired for initiation of inner ear development. [3]” http://en.wikipedia.org/wiki/FGF19FGFR3, fibroblast growth factor receptor 3 (codiert für 806 [isoform 2: 808] amino acids)(Wiederholung bis STAT5B:) "Function: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growthfactors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essentialrole in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normalskeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotesapoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of theinner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signalingcascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediatesactivation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinaseactivation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Overexpressedor constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B.”TOCRIS summary for FGFR3:"Fibroblast growth factors (FGFs) (FGF1 - 10 and 16 - 23) are mitogenic signaling molecules that have roles inangiogenesis, wound healing, cell migration, neural outgrowth and embryonic development. FGFs bind heparan sulfateglycosaminoglycans (HSGAGs), which facilitates dimerization (activation) of FGF receptors (FGFRs). FGFRs aretransmembrane catalytic receptors that have intracellular tyrosine kinase activity. There are four human genesencoding FGFRs, which produce seven different receptors (FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b,FGFR3c and FGFR4) due to alternative splicing events occurring both in the extracellular and intracellularregions. The alternative splice isoforms are generally tissue specific: the b isoform is expressed in epithelial tissue,418 http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF4&search=FGF4 und http://en.wikipedia.org/wiki/FGF4 (21.12. 2012)419 http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF5 (21. 12. 2012)420 http://en.wikipedia.org/wiki/FGF5

231whereas the c isoform is expressed in mesenchymal tissue. HSGAG-FGF-FGFR binding initiates FGFR dimerization,enabling the cytoplasmic kinase domains to transphosphorylate tyrosine residues and become activated. HSGAGs alsofunction to stabilize FGF-FGFR binding and prevent FGF degradation. FGFRs couple to the PLCgamma, MAPK andPI3-K/Akt intracellular signaling cascades and there is evidence of cross talk with the Notch signaling pathway. Inaddition, some activated FGF-FGFR complexes are endocytosed and function directly in the cytosol and/or nucleus ofthe cell. Mutations in FGFR genes are the cause of several human developmental disorders characterized by skeletalabnormalities such as achondroplasia, and upregulation of FGFR expression may lead to cell transformation andcancer.”"Subunit: Monomer. Homodimer after ligand binding. Interacts with FGF1, FGF2, FGF4, FGF6; FGF8, FGF9, FGF10,FGF17, FGF18, FGF19, FGF20 and FGF23 (in vitro). Interacts with KLB. Affinity for fibroblast growth factors(FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases theaffinity for FGF19 and FGF21. Interacts with PIK3R1, PLCG1, SOCS1 and SOCS3.” 421Für dieses Gen führt UniProtKB/Swiss-Prot (FGFR3_HUMAN, P22607)folgende durch Mutationen verursachte Defekte auf (Involvement in disease;http://www.uniprot.org/uniprot/P22607#section_comments; last modified 28 November 2012):"Defects in FGFR3 are the cause of achondroplasia (ACH) [MIM:100800]. ACH is an autosomal dominant disease and is the mostfrequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal(rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. Ref.12Ref.14 Ref.30 Ref.31 Ref.32 Ref.37Defects in FGFR3 are the cause of Crouzon syndrome with acanthosis nigricans (CAN) [MIM:612247]. Classic Crouzon diseasewhich is caused by mutations in the FGFR2 gene is characterized by craniosynostosis (premature fusion of the skull sutures), andfacial hypoplasia. Crouzon syndrome with acanthosis nigricans (a skin disorder characterized by pigmentation anomalies), CAN, isconsidered to be an independent disorder from classic Crouzon syndrome. CAN is characterized by additional more severe physicalmanifestation, such as Chiari malformation, hydrocephalus, and atresia or stenosis of the choanas, and is caused by a specific mutation(Ala-391 to Glu) in the transmembrane domain of FGFR3. It is proposed to have an autosomal dominant mode of inheritance. Ref.36Ref.48 Ref.53 Ref.54 Ref.60Defects in FGFR3 are a cause of thanatophoric dysplasia type 1 (TD1) [MIM:187600]; also known as thanatophoric dwarfism orplatyspondylic lethal skeletal dysplasia Sand Diego type (PLSD-SD). TD1 is the most common neonatal lethal skeletal dysplasia.Affected individuals display features similar to those seen in homozygous achondroplasia. It causes severe shortening of the limbswith macrocephaly, narrow thorax and short ribs. In the most common subtype, TD1, femur are curved. Ref.33 Ref.34 Ref.38 Ref.41Ref.44 Ref.46Defects in FGFR3 are a cause of thanatophoric dysplasia type 2 (TD2) [MIM:187601]. It is a neonatal lethal skeletal dysplasiacausing severe shortening of the limbs, narrow thorax and short ribs. Patients with thanatophoric dysplasia type have straight femursand cloverleaf skull.Defects in FGFR3 are a cause of hypochondroplasia (HCH) [MIM:146000]. HCH is an autosomal dominant disease and ischaracterized by disproportionate short stature. It resembles achondroplasia, but with a less severe phenotype.Defects in FGFR3 are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of theurinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladdercancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types ofbladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cellsthat make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmentalinfluences. Note=Somatic mutations can constitutively activate FGFR3.Defects in FGFR3 are a cause of cervical cancer (CERCA) [MIM:603956]. A malignant neoplasm of the cervix, typicallyoriginating from a dysplastic or premalignant lesion previously present at the active squamocolumnar junction. The transformationfrom mild dysplastic to invasive carcinoma generally occurs slowly within several years, although the rate of this process varieswidely. Carcinoma in situ is particularly known to precede invasive cervical cancer in most cases. Cervical cancer is stronglyassociated with infection by oncogenic types of human papillomavirus.Defects in FGFR3 are the cause of camptodactyly tall stature and hearing loss syndrome (CATSHL syndrome) [MIM:610474].CATSHL syndrome is an autosomal dominant syndrome characterized by permanent and irreducible flexion of one or more fingers ofthe hand and/or feet, tall stature, scoliosis and/or a pectus excavatum, and hearing loss. Affected individuals have developmental delayand/or mental retardation, and several of these have microcephaly. Radiographic findings included tall vertebral bodies with irregularborders and broad femoral metaphyses with long tubular shafts. On audiological exam, each tested member have bilateralsensorineural hearing loss and absent otoacoustic emissions. The hearing loss was congenital or developed in early infancy, progressedvariably in early childhood, and range from mild to severe. Computed tomography and magnetic resonance imaging reveal that thebrain, middle ear, and inner ear are structurally normal.Defects in FGFR3 are a cause of multiple myeloma (MM) [MIM:254500]. MM is a malignant tumor of plasma cells usually arisingin the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria andanemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrantantibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis maydevelop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknownsignificance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving FGFR3 is found in multiple myeloma.Translocation t(4;14)(p16.3;q32.3) with the IgH locus.Defects in FGFR3 are a cause of lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]; also known as Levy-Hollister syndrome. LADDS is a form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development oftwo or more ectodermal structures. LADDS is an autosomal dominant syndrome characterized by aplastic/hypoplastic lacrimal andsalivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. Inaddition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitaliahave been reported. Craniosynostosis and severe syndactyly are not observed. Ref.59Defects in FGFR3 are a cause of keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]; also known as pigmented moles.Epidermal nevi of the common, non-organoid and non-epidermolytic type are benign skin lesions and may vary in their extent from a421 Alle drei Zitate nach http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR3&search=FGFR3 (21. 12. 2012)

230ersten Hinweise auf eventuelle Folgen von Fehlfunktionen entnehmen; weitereInformationen in den aufgeführten Quellen):FGF4, fibroblast growth factor 4 (codiert für 206 amino acids)"Subunit: Interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) andtheir receptors is increased by heparan sulfate glycosaminoglycans that function as coreceptors.”"Fibroblast growth factor 4 is a protein that in humans is encoded by the FGF4 gene.[1][2]The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family memberspossess broad mitogenic and cell survival activities and are involved in a variety of biological processes includingembryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene wasidentified by its oncogenic transforming activity. This gene and FGF3, another oncogenic growth factor, are locatedclosely on chromosome 11. Co-amplification of both genes was found in various kinds of human tumors. Studies on themouse homolog suggested a function in bone morphogenesis and l<strong>im</strong>b development through the sonic hedgehog (SHH)signaling pathway.[2]" 418FGF5, fibroblast growth factor 5 (codiert für 268 amino acids)"Subunit: Interacts with FGFR1 and FGFR2.” 419"The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family memberspossess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, includingembryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene wasidentified as an oncogene, which confers transforming potential when transfected into mammalian cells. Targeteddisruption of the homolog of this gene in mouse resulted in the phenotype of abnormally long hair, which suggested afunction as an inhibitor of hair elongation. Alternatively spliced transcript variants encoding different isoforms havebeen identified.[3]The disruption of FGF5 expression in mammals increases the length of the anagen (growth) phase of the haircycle, resulting in a phenotype of extremely long hair. This has been shown in many species, including cats,[4]dogs,[5] mice,[6] rabbits, sheep and goats (the so-called angora mutation)[7][8] and even elephants andmammoths.[9] FGF5 also affects the hair cycle in humans; blocking FGF5 in the human scalp (by applying a herbalextract that blocked FGF5) extends the hair cycle, resulting in less hair fall and increased hair growth.[10]." 420FGF19, fibroblast growth factor 19 (codiert für 216 amino acids)"Function: Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression,following positive regulation of the JNK and ERK1/2 cascades. St<strong>im</strong>ulates glucose uptake in adipocytes. Activityrequires the presence of KLB and FGFR4."http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF19&search=FGF19"This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected onlyin fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to berequired for initiation of inner ear development. [3]” http://en.wikipedia.org/wiki/FGF19FGFR3, fibroblast growth factor receptor 3 (codiert für 806 [isoform 2: 808] amino acids)(Wiederholung bis STAT5B:) "Function: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growthfactors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essentialrole in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normalskeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotesapoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of theinner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signalingcascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediatesactivation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinaseactivation or <strong>im</strong>pair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Overexpressedor constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B.”TOCRIS summary for FGFR3:"Fibroblast growth factors (FGFs) (FGF1 - 10 and 16 - 23) are mitogenic signaling molecules that have roles inangiogenesis, wound healing, cell migration, neural outgrowth and embryonic development. FGFs bind heparan sulfateglycosaminoglycans (HSGAGs), which facilitates d<strong>im</strong>erization (activation) of FGF receptors (FGFRs). FGFRs aretransmembrane catalytic receptors that have intracellular tyrosine kinase activity. There are four human genesencoding FGFRs, which produce seven different receptors (FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b,FGFR3c and FGFR4) due to alternative splicing events occurring both in the extracellular and intracellularregions. The alternative splice isoforms are generally tissue specific: the b isoform is expressed in epithelial tissue,418 http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF4&search=FGF4 und http://en.wikipedia.org/wiki/FGF4 (21.12. 2012)419 http://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF5 (21. 12. 2012)420 http://en.wikipedia.org/wiki/FGF5

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!